Macmillon Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-11-2024
- Paid Up Capital ₹ 1.94 M
as on 16-11-2024
- Company Age 36 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.00 Cr
as on 16-11-2024
- Satisfied Charges ₹ 4.59 Cr
as on 16-11-2024
About Macmillon Pharmaceuticals
The Corporate was formerly known as Macmillon Pharmaceuticals Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.94 M.
The company currently has active open charges totaling ₹3.00 Cr. The company has closed loans amounting to ₹4.59 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sahil Mahajan, Naresh Mahajan, Asar Khan, and One other member serve as directors at the Company.
- CIN/LLPIN
U24231PB1988PTC008661
- Company No.
008661
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Sep 1988
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- LocationPunjab, Punjab
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Macmillon Pharmaceuticals?
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sahil Mahajan | Director | 25-Jun-2005 | Current |
Naresh Mahajan | Director | 01-Apr-1996 | Current |
Asar Khan | Whole-Time Director | 20-Dec-2014 | Current |
Satish Kumar | Director | 03-Oct-2017 | Current |
Financial Performance and Corporate Structure Insights of Macmillon Pharmaceuticals.
Macmillon Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Macmillon Pharmaceuticals?
In 2023, Macmillon Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Ravenbhel Pharmaceuticals Private LimitedActive 24 years 8 days
Sahil Mahajan and Naresh Mahajan are mutual person
- Ravenmac Pharmaceuticals Private LimitedActive 14 years 9 months
Sahil Mahajan and Naresh Mahajan are mutual person
- Salutemlab Formulations Private LimitedActive 1 year 2 months
Sahil Mahajan and Naresh Mahajan are mutual person
- Salutemlife Sciences Private LimitedActive 1 year 2 months
Sahil Mahajan and Naresh Mahajan are mutual person
- Polycoatt Films Private LimitedActive 11 months 18 days
Sahil Mahajan and Naresh Mahajan are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Bank Of Baroda Creation Date: 23 Jul 2011 | ₹3.00 Cr | Open |
Bank Of Baroda Creation Date: 24 Feb 2014 | ₹3.40 M | Satisfied |
Bank Of Baroda Creation Date: 23 Dec 2013 | ₹3.90 M | Satisfied |
How Many Employees Work at Macmillon Pharmaceuticals?
Macmillon Pharmaceuticals has a workforce of 312 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Macmillon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Macmillon Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.